Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The Find It Early Act requires no cost-sharing for additional breast screening and diagnostic imaging for people at increased breast cancer risk or deemed to need imaging by a provider. It applies across private group and individual plans, Medicare (including Medicare Advantage), Medicaid, TRICARE, and Veterans Affairs, using the most recent ACR Appropriateness Criteria or NCCN guidelines and BI-RADS density definitions.
Lib-left emphasizes access and equity; conservatives emphasize mandates and costs
Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific statutory amendments to require no-cost-sharing breast imaging for specified higher-risk individuals across multiple federal and private coverage programs.
The Find It Early Act requires no cost-sharing for additional breast screening and diagnostic imaging for people at increased breast cancer risk or deemed to need imaging by a provider.
It applies across private group and individual plans, Medicare (including Medicare Advantage), Medicaid, TRICARE, and Veterans Affairs, using the most recent ACR Appropriateness Criteria or NCCN guidelines and BI-RADS density definitions.
There is no frequency limit on covered screening/diagnostic imaging; most provisions take effect January 1, 2026, with a narrow state delay for Medicaid plan law changes.
Policy is non-ideological and beneficiary-friendly, aiding support, but federal costs and insurer pushback reduce odds.
Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific statutory amendments to require no-cost-sharing breast imaging for specified higher-risk individuals across multiple federal and private coverage programs. It integrates directly into existing statutory frameworks and sets effective dates.
Lib-left emphasizes access and equity; conservatives emphasize mandates and costs
These are examples from the analysis, not a ranked list of the most-affected groups.
Lib-left emphasizes access and equity; conservatives emphasize mandates and costs
Generally strongly supportive.
The bill removes financial barriers to cancer detection for high-risk and medically underserved groups, aligns coverage with clinical guidelines, and extends protections to veterans and military beneficiaries.
Generally supportive but cautious.
The goal of removing cost barriers for clinically indicated imaging is sensible, but implementation, cost control, and evidence of net benefit should be monitored.
Skeptical.
While valuing cancer detection, this imposes new federal mandates on insurers and public programs, removes cost-sharing, and allows potentially open-ended imaging without frequency limits.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Policy is non-ideological and beneficiary-friendly, aiding support, but federal costs and insurer pushback reduce odds.
The bill has not accumulated any surfaced votes yet.
Lib-left emphasizes access and equity; conservatives emphasize mandates and costs
Policy is non-ideological and beneficiary-friendly, aiding support, but federal costs and insurer pushback reduce odds.
Relative to its intended legislative type, this bill is a clearly articulated substantive policy change that provides specific statutory amendments to require no-cost-sharing breast imaging for specified higher-risk ind…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.